
|Articles|May 15, 2004
AMO redefines position with Pfizer purchase
Advanced Medical Optics (AMO, Santa Ana, CA) redefined its position in the ophthalmic community when it reached a definitive agreement April 21 to acquire Pfizer's surgical ophthalmology business for $450 million in cash. The deal will boost AMO's revenue base by 25% and allow the company bragging rights to the Healon line of viscoelastic products, the CeeOn and Tecnis IOLs, and the Baerveldt glaucoma shunt.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
3
Dompé initiates phase 3 Orunea trial of cenegermin-bkbj in PCED
4
Beyond the basics: John Berdahl, MD, on AI-driven IOL planning, PCO prevention, and lessons from the mission field
5





















